Growth Height Research
Specialists in the Institute of Endocrinology and Diabetes at Schneider Children's are continuing research to test the influence of a unique nutritional growth formula on the height of healthy but short adolescents. The research follows the success of the initial 6-year study which found that the special formula given to healthy, short and skinny children aged 3-9 significantly improved their height and weight while maintaining a normal BMI (Body/Mass Index – the ratio between weight and height).
The current research is aimed at girls over the age of 9 and boys over the age of 10 whose height and weight fall beneath the 10th percentile, yet do not suffer from growth hormone deficiency or intestinal disease, and who have not yet entered puberty. Participants in the study will be randomly divided into the research group and a control group. During the first 6 months, the children will be treated with the research formula or a placebo. During the following 6 months, all the children will be treated with the research formula. The aim of the research is to prove that that the formula for adolescents will spur their growth as opposed to those who do not receive it. All the participants will receive the unique formula free of charge. The study has been approved by the Helsinki Committee at Schneider Children's.
Heading the research at Schneider Children's is Prof. Moshe Phillip, Director of the Institute of Endocrinology and Diabetes, Prof. Raanan Shamir, Director of the Institute of Gastroenterology, Nutrition and Liver Diseases, Prof. Leora Harel, senior physician in the Institute of Endocrinology and Diabetes and Dr. Michal Yaakobovich-Gavan, Dietician and Research in the Institute of Endocrinology and Diabetes.